Imricor Medical Systems, Inc. Stock
Equities
IMR
AU0000054942
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 AUD | -1.11% | -8.25% | -21.93% |
May. 15 | Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT | CI |
May. 15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call |
Sales 2024 * | 3.81M 5.78M | Sales 2025 * | 8.74M 13.26M | Capitalization | 59.43M 90.16M |
---|---|---|---|---|---|
Net income 2024 * | -14M -21.24M | Net income 2025 * | -11M -16.69M | EV / Sales 2024 * | 12.5 x |
Net cash position 2024 * | 11.7M 17.75M | Net cash position 2025 * | 13.7M 20.78M | EV / Sales 2025 * | 5.23 x |
P/E ratio 2024 * |
-4.44
x | P/E ratio 2025 * |
-5.74
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.1% |
Latest transcript on Imricor Medical Systems, Inc.
1 day | -1.11% | ||
1 week | -8.25% | ||
Current month | -8.25% | ||
1 month | -2.20% | ||
3 months | -5.32% | ||
6 months | -19.09% | ||
Current year | -21.93% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Wedan
CEO | Chief Executive Officer | 56 | 05-12-31 |
Jonathon Gut
DFI | Director of Finance/CFO | - | 19-12-31 |
Kate Lindborg
CTO | Chief Tech/Sci/R&D Officer | - | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anita Messal
BRD | Director/Board Member | - | 21-02-28 |
Peter McGregor
BRD | Director/Board Member | 58 | 19-04-30 |
Mark Tibbles
BRD | Director/Board Member | 57 | 14-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.445 | -1.11% | 40,874 |
24-06-06 | 0.45 | -1.10% | 195,359 |
24-06-05 | 0.455 | +1.11% | 65,104 |
24-06-04 | 0.45 | -4.26% | 50,247 |
24-06-03 | 0.47 | -3.09% | 158,138 |
Delayed Quote Australian S.E., June 07, 2024 at 02:11 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 59.43M | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.49% | 66.45B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B | |
+22.61% | 30.98B |
- Stock Market
- Equities
- IMR Stock